SAT453 Endocrine Related Adverse Events Of Immune Checkpoint Inhibitors In Cancer Patients Visiting Tertiary Care Center In Saudi Arabia

Disclosure: A.M. Alqahtani: None. A.S. Alghassab: None. L.A. Alghamdi: None. M. Almalki: None. Introduction: Immune checkpoint inhibitors (ICIs) have been approved for the treatment of a different types of cancers. Those agents may result in exaggerated immune response leading to numerous toxicities...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed Alqahtani, Ali, Saad Alghassab, Abdulmohsen, Ahmed Alghamdi, Lamia, Almalki, Mussa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555295/
http://dx.doi.org/10.1210/jendso/bvad114.1928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555295/
http://dx.doi.org/10.1210/jendso/bvad114.1928

Ejemplares similares